Research programme: influenza virus DNA vaccine - GenvaxAlternative Names: GVX-2323; MMI-2323
Latest Information Update: 07 May 2010
At a glance
- Originator Genvax
- Class DNA vaccines; Influenza virus vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 30 Sep 2006 Preclinical trials in Influenza virus infections in United Kingdom (Parenteral)